Tropical Weight Loss
Tropical Weight Loss
Photo: Nicola Barts
In the control group, fasting glucose, HbA1c and fasting insulin increased. One-third (34.3%) of men treated with testosterone saw remission of their diabetes; almost half (46.6%) achieved normal glucose regulation with antidiabetic treatment and a vast majority (83.1%) reached their target level of HbA1c.
Stomach problems: Fat burners can lead to stomach issues such as gas or bloating, diarrhoea, constipation, and other issues with bowel movements...
Read More »
Weight loss A study published in 2003 found that switching from drinking cold water to hot water could increase weight loss. Researchers found that...
Read More »
Amino acids, specifically, are generally safe to use every day, as long as they're not consumed in huge amounts. Because the nutritional needs of...
Read More »
around 39 degrees Fahrenheit While fat cells will die at four degrees Celsius (around 39 degrees Fahrenheit), CoolSculpting® (a.k.a. cryolipolysis)...
Read More »The objective of the researchers’ study was to determine if men with Type 2 diabetes who also exhibit hypogonadism, when treated with testosterone in addition to their regular diabetes treatment, would demonstrate improved glycemic control and insulin sensitivity, and possibly eventually experience remission of Type 2 diabetes. The investigators observed 356 men in a single urology practice clinic over 11 years. All patients received standard diabetes treatment, which included mandatory educational courses and materials. In addition, 178 men with a mean age of 62 years received 1,000 milligrams of subcutaneously injected, slow-release testosterone every 12 weeks after an initial six-week interval. The 178 subjects, mean age 64 years, who opted out of the testosterone therapy served as the control group. The researchers took numerous measurements, including height, weight, waist circumference, blood pressure, hemoglobin, fasting glucose, HbA 1c (the average amount of glucose in blood over a six- or 12-week period), insulin, heart rate, lipids, highly sensitive C-reactive protein and total testosterone, among others. They also assessed quality of life using the Aging Males’ Symptoms scale. Erectile function was also assessed, using the International Index of Erectile Function. Assessment of these clinical metrics was performed at least twice a year, and data over 11 years were analyzed. The results showed that the men treated with testosterone had “significant progressive and sustained reductions in their body weight, fasting glucose, HbA 1c and fasting insulin over the treatment period,” the authors wrote. In the control group, fasting glucose, HbA 1c and fasting insulin increased. One-third (34.3%) of men treated with testosterone saw remission of their diabetes; almost half (46.6%) achieved normal glucose regulation with antidiabetic treatment and a vast majority (83.1%) reached their target level of HbA 1c . Patients in the control group saw no remission of diabetes or reduction in glucose or HbA 1c levels.
Baking soda mixed with apple cider vinegar Combining the two also creates a chemical reaction that produces gas. Therefore, this mixture may cause...
Read More »
Mix 1–2 tablespoons (15–30 ml) of apple cider vinegar with 1 cup (237 ml) of water. Ingesting undiluted vinegar of any kind can damage your throat...
Read More »In addition, there were fewer deaths, myocardial infarctions, strokes and diabetic complications in the group treated with testosterone. The research indicates that long-term treatment with testosterone is potentially a novel additional therapy for men with Type 2 diabetes and hypogonadism, the authors wrote. “The clinical significance of these results is further enhanced by the fact that one-third of men with Type 2 diabetes have hypogonadism. Hence, physicians encounter men with hypogonadism and diabetes very frequently. It is remarkable that while Type 2 diabetes mellitus leads to hypogonadism, treatment of hypogonadism results in remission of diabetes itself,” the authors wrote. Going forward, prospective randomized controlled trials are needed to confirm the data. One such trial is currently in progress. Dandona is one of the world’s leading experts in the treatment of diabetes and vascular disease. He is also the ex-chief of endocrinology at UB and founder of the Diabetes and Endocrinology Center of Western New York, which is sponsored by the Jacobs School and Kaleida Heath. He sees patients at UBMD Internal Medicine. Dandona’s co-authors on the study include Karim Sultan Haider and Ahmad Haider, urologists in Bremerhaven, Germany; Farid Saad, a consultant to Medical Affairs Andrology at Bayer AG in Berlin; Gheorghe Doros from the Department of Epidemiology and Biostatistics at the Boston University School of Public Health; Markolf Hanefeld from GWT-TU Dresden GmbH and Medizinische Klinik, Universitätsklinikum Carl Gustav Carus, in Dresden; Sandeep Dhindsa from the Division of Endocrinology, Diabetes and Metabolism at Saint Louis University; and Abdulmaged Traish from the Department of Urology at the Boston University School of Medicine.
DrugPatentWatch® Generic Entry Outlook for Ozempic By analyzing the patents and regulatory protections it appears that the earliest date for...
Read More »
Mild side effects that have been reported with Ozempic include: gas and burping* dizziness* nausea* vomiting. diarrhea. abdomen (belly) pain....
Read More »
Eat late, gain weight? This myth has been around for years, and although some people could swear that their late-night eating habits do make them...
Read More »
Research has found that men tend to lose more weight from their trunk area, while women lose more weight from their hips. Nov 30, 2020
Read More »
Promotion
Promotion
Promotion
Promotion